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Global Variation of Nutritional
Status in Children Undergoing
Chronic Peritoneal Dialysis:
A Longitudinal Study of the
International Pediatric Peritoneal
Dialysis Network
Franz Schaefer1, Laura Benner2, Dagmara Borzych-Dużałka3, Joshua Zaritsky4, Hong Xu5,
Lesley Rees6, Zenaida L. Antonio7, Erkin Serdaroglu8, Nakysa Hooman 9, Hiren Patel10,
Lale Sever11, Karel Vondrak12, Joseph Flynn13, Anabella Rébori14, William Wong15,
Tuula Hölttä16, Zeynep Yuruk Yildirim17, Bruno Ranchin18, Ryszard Grenda19, Sara Testa20,
Dorota Drożdz21, Attila J. Szabo22, Loai Eid23, Biswanath Basu24, Renata Vitkevic25,
Cynthia Wong26, Stephen J. Pottoore27, Dominik Müller28, Ruhan Dusunsel29,
Claudia Gonzalez Celedon30, Marc Fila 31, Lisa Sartz32, Anja Sander2, Bradley A. Warady33 &
International Pediatric Peritoneal Dialysis Network (IPPN) Registry*
While children approaching end-stage kidney disease (ESKD) are considered at risk of uremic anorexia
and underweight they are also exposed to the global obesity epidemic. We sought to investigate the
variation of nutritional status in children undergoing chronic peritoneal dialysis (CPD) around the globe.
The distribution and course of body mass index (BMI) standard deviation score over time was examined
prospectively in 1001 children and adolescents from 35 countries starting CPD who were followed in
the International Pediatric PD Network (IPPN) Registry. The overall prevalence of underweight, and
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overweight/obesity at start of CPD was 8.9% and 19.7%, respectively. Underweight was most prevalent
in South and Southeast Asia (20%), Central Europe (16.7%) and Turkey (15.2%), whereas overweight
and obesity were most common in the Middle East (40%) and the US (33%). BMI SDS at PD initiation
was associated positively with current eGFR and gastrostomy feeding prior to PD start. Over the course
of PD BMI SDS tended to increase on CPD in underweight and normal weight children, whereas it
decreased in initially overweight patients. In infancy, mortality risk was amplified by obesity, whereas
in older children mortality was markedly increased in association with underweight. Both underweight
and overweight are prevalent in pediatric ESKD, with the prevalence varying across the globe. Late
dialysis start is associated with underweight, while enteral feeding can lead to obesity. Nutritional
abnormalities tend to attenuate with time on dialysis. Mortality risk appears increased with obesity in
infants and with underweight in older children.
The nutritional status is a principal concern when caring for children undergoing chronic peritoneal dialysis
(CPD). While early studies revealed providing sufficient nutrition was essential for adequate growth in this population, advances in enteral feeding practices have enabled the elimination of underweight but have not improved
linear growth as much as expected1–3. Recent concerns have emerged on the potential for adverse effects of excessive caloric intake in patients who receive supplemental feeding1–3.
The majority of published studies assessing the nutritional status of dialyzed children were performed at
highly specialized pediatric dialysis units in North America and Western Europe. In contrast, on a global scale
the risk of nutritional abnormalities in individual regions and countries is likely to be affected by a range of medical and non-medical factors including the patient case-mix regarding age, underlying disease and co-morbidities,
national economic strength and healthcare expenditure, cultural acceptability of dietary and feeding prescriptions, availability of special formula diets and enteral feeding equipment, and differences in local, national or
regional nutritional recommendations4.
The International Pediatric Peritoneal Dialysis Network (IPPN) has been collecting comprehensive clinical
and laboratory data in a standardized manner from children undergoing CPD worldwide since 2007. Since these
data include detailed anthropometric measures, feeding prescriptions and outcome measures, it provides an
opportunity to address the global demographics of nutritional abnormalities in children receiving CPD.
The objective of this study was to examine and follow prospectively the nutritional status of 1,001 children
commencing CPD around the globe, analyze factors associated with the nutritional status at the start and during
the course of dialysis, and to analyze the impact of nutritional abnormalities on patient survival.

Methods

Data collection.

The IPPN Registry was established in 2007 and currently collects comprehensive clinical
and laboratory information from children undergoing CPD at 95 pediatric dialysis centers in 37 countries around
the globe. Patient status is updated every 6 months via an Internet-based web platform (www.pedpd.org). The
complete list of data items collected has been published previously2,4. Data is automatically checked for plausibility and completeness. Data protection is ensured by pseudonymized data input. The study is performed in accordance with the relevant medical association’s professional codes of conduct with the Declaration of Helsinki from
2008. Approval for the registry project was obtained from The Children’s Mercy Hospital Pediatric Institutional
Review Board, Kansas City, USA and local Institutional Review Boards or ethical committees. Informed consent
was obtained from the patients and/or their legal guardians as required by local review boards.

Calculation of BMI SDS and eGFR. Body Mass Index (BMI), i.e. weight/height2 (kg/m2), was normalized to standard deviation scores (SDS) according to height age, utilizing the WHO (2006) and CDC (2000)
standards for children aged younger and older than 5 years, respectively (see www.who.int/childgrowth/en/)5,6.
Normalization to height age, i.e. the chronological age of a child with the same height growing at the 50th height
percentile, was made to adjust for the high prevalence of growth failure in the cohort7. BMI SDS values were used
to categorize patients into three BMI groups: underweight (<2.5th percentile, i.e. <−2 SDS), normal (2.5th to 85th
percentile, i.e. −2 to 1.036 SDS), overweight (>85th −95th percentile, i.e. >1.036 to 1.645 SDS), and obesity (>95th
percentile, i.e. >1.645 SDS). The Schwartz bedside formula was used to estimate GFR at initiation of CPD8.
Statistics. Data collection was complete for all observations except residual urine output (7.6% missing data),

daily ultrafiltration rate (5.2%), eGFR (1.2%), total PD fluid turnover and dialytic glucose exposure (0.8%), PD
modality (0.5%), serum bicarbonate (0.3%), serum albumin (0.2%), and estimated dry weight (0.2%). Multiple
imputation by chained equations was conducted to replace these missing values9. All analyses were performed
using the imputed dataset. Additionally, sensitivity analyses were performed using only cases with complete data
sets.
ANOVA or Kruskal-Wallis tests were conducted to compare differences between BMI groups. Differences in
proportions were assessed using Chi2 tests. Linear mixed modeling was used to identify factors affecting BMI SDS
at baseline and during follow-up. The initial cross sectional model included age, sex, eGFR, gross national income
(GNI), renal diagnosis, presence of comorbidities, ethnicity, urine output, nutritional support (oral caloric supplements, nasogastric tube (NGT) and gastrostomy feeding), and growth hormone use as independent variables.
The region of residence was accounted for as random intercept. For the longitudinal analysis, the change in BMI
SDS between two observations, projected to 12 months, was used as the dependent variable and region and
patients were used as nested random effects. Potential covariates included in the initial model were age at baseline,
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sex, presence of comorbidities, renal diagnosis, GNI and the time-varying variables BMI SDS, height SDS, eGFR,
% deviation from estimated dry weight, PD modality, duration of PD, serum albumin, serum bicarbonate, total
PD fluid volume, urine output, ultrafiltration, growth hormone use, nutritional support, glucose exposure, biocompatible PD fluid use, and amino acid PD fluid use. A stepwise variable selection procedure was applied to
identify the relevant covariates for the cross sectional model as well as for the longitudinal model, using p = 0.2
as a cutoff criterion for model entry.
Kaplan–Meier analysis with log-rank testing was used to assess differences in patient survival. Cox proportional hazard modeling with time dependent covariates and interaction term was applied to identify risk factors
of death on dialysis.
Data were analyzed using SAS, version 9.3 (SAS Institute, Inc., Cary, NC), and R, version 3.1.110.

Results

Study population.

All children and adolescents enrolled in the IPPN registry with initiation of CPD
between March 2007 and December 2014 were analyzed for this study. Five patients with syndromic and metabolic disorders associated with intrinsic abnormalities of growth and body composition were excluded from the
analysis. The final dataset comprised a total of 1,001 incident patients from 85 nephrology centers in 35 countries.
Children originated from Western Europe (n = 300), Central Europe (n = 120), Turkey (n = 105), the Middle
East (n = 15), China and Hong Kong (n = 77), Korea (n = 24), India and South East Asia (n = 30), New Zealand
(n = 18), USA (n = 97), Canada (n = 13) and Latin America (n = 202). One or more comorbidities were reported
in 369 patients (35.6%); these included mainly defined syndromic disorders (n = 107), impaired cognitive development (n = 119), cardiac (n = 130) and pulmonary abnormalities (n = 52).
Of the 1,001 patients, 702 (70%) patients had at least two BMI records available. Median follow-up time was
14.5 (IQR 17.8) months. Altogether, the data set contained 2,931 follow-up entries.

Nutritional status at dialysis initiation. The overall prevalence of underweight, normal weight and over-

weight/obesity at the start of CPD was 8.9%, 71.4%, and 19.7%, respectively. The detailed patient characteristics according to nutritional status at dialysis entry are shown in Table 1. Overweight/obese children originated
from countries with higher GNI per capita, had higher eGFR at CPD initiation and were more growth retarded.
Gastrostomy feeding was performed in almost 17% of the overweight children as compared to 8% and 6% in the
normal and low BMI groups (p < 0.001 for comparison of gastrostomy feeding between overweight and normal,
as well as between overweight and low BMI). Children starting PD with underweight more often received amino
acid PD fluid than children without underweight (p = 0.013).
The distribution of underweight, normal weight, and overweight/obese patients according to geographical
region is depicted in Fig. 1. The prevalence of nutritional abnormalities varied significantly across world regions.
Underweight was most prevalent in South and Southeast Asia (20%), followed by Central Europe (16.7%) and
Turkey (15.2%), whereas overweight and obesity were most common in the Middle East (40%) and the US (33%).
The prevalence of underweight was highest in the first year of life (14.2%), decreasing to 6.5%, 9.4% and
7.7% in children aged 1–<6, 6–12 and older than 12 years, respectively (Fig. S1 in supplement). The prevalence of underweight was correlated with the eGFR at initiation of PD, increasing from 5.3% at eGFR 9–12 ml/
min/1.73 m2 to 11% at eGFR < 6 ml/min/1.73 m2 (p = 0.03) (see also Fig. S2). The prevalence of obesity was higher
in the younger children than in adolescents, whereas the prevalence of being overweight was largely independent
of age (see Fig. S1).
By multivariate analysis, BMI SDS at dialysis initiation was positively predicted by eGFR and the use of gastrostomy feeding and negatively predicted by the presence of comorbidities, whereas age, sex, ethnicity, GNI,
renal diagnosis, and growth hormone use were not predictive (Table S1).

Enteral feeding practices.

To further explore and compare regional characteristics in nutrition management, enteral feeding patterns were investigated. Enteral (NGT or gastrostomy) feeding was used at baseline in
57.4%, 32.9%, 5.6%, and 2.3% of children <1, 1–<6, 6–12 and >12 years, respectively (p < 0.001). The variation
of feeding practices varied markedly by region (Fig. 2). Enteral feeding was rarely applied in Central Europe,
Turkey, India, South East Asia, and China. Gastrostomy usage was confined to North America, Western Europe,
Korea and New Zealand. Among the 386 children <6 years, 166 were followed for at least 12 months on dialysis.
The fraction of children with enteral tube feeding was 38% at baseline and 41% at follow up (ns).

Changes in nutritional status with time on CPD. Changes in BMI SDS were analyzed using 702 patients

with at least two available BMI records. During a median follow-up time of 15 (interquartile range 18) months,
BMI SDS tended to increase on CPD in both underweight and normal weight children, whereas it decreased in
the overweight patients (Fig. 3). Out of 74 underweight children at the start of CPD, 51.4% were non-underweight
at last observation; among 125 overweight/obese children at CPD initiation, 36.0% achieved a normal BMI at
follow-up.
Gastrostomy feeding was associated with an increase in BMI SDS during follow-up (Table 2). Additional
factors independently associated with a positive change in BMI SDS included a lower BMI SDS and higher height
SDS, higher serum albumin and the diagnosis of CAKUT. In contrast, greater fluid overload (expressed as % deviation from estimated dry weight) was predictive of a negative change in BMI SDS during follow-up.

Nutrition and mortality.

A total of 54 children died during the observation period. The most common
causes of death were non-PD related infections (39%), followed by congestive heart failure (17%), PD-related
infections (7%) and malignances (7%). The 1-, 2- and 4-year survival rates were 91%, 84%, and 74% in patients
who were underweight at last observation, as compared to 95%, 93% and 89% in those with final higher BMI SDS
values (p = 0.03) (Fig. 4). Cox proportional hazard analysis identified the presence of comorbidities and younger
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Total population

BMI < 2.5th percentile

BMI 2.5th–85th pct

BMI > 85th pct

N = 1001

n = 89

n = 715

n = 197

Country GNI per capita (1000$)

27.1 ± 13.6

24.0 ± 13.2

27.0 ± 13.4

28.6 ± 14.5

0.03

Age (yrs)

8.5 ± 5.8

7.7 ± 5.9

8.7 ± 5.8

8.1 ± 5.8

0.18

Male gender

550 (55%)

50 (56.2%)

388 (54.3%)

112 (56.9%)

0.79

424 (42.4%)

44 (49.4%)

291 (40.7%)

89 (45.2%)

Renal diagnosis
CAKUT

P

0.24

Glomerulopathy

388 (38.8%)

30 (33.7%)

292 (40.8%)

66 (33.5%)

Other

189 (18.9%)

15 (16.9%)

132 (18.5%)

42 (21.3%)

Comorbidities

355 (35.5%)

38 (42.7%)

250 (35.0%)

67 (34.0%)

0.32

eGFR at PD start (ml/min/1.73 m2)

8.0 (5.3)

7.3 (5.1)

7.9 (5.2)

8.8 (5.6)

0.01

Urine output (L/m2/d)

0.61 (0.94)

0.53 (0.85)

0.63 (0.93)

0.56 (1.05)

0.80

222 (22.6%)

23 (25.8%)

156 (21.8%)

43 (21.8%)

PD modality
CAPD

0.51

APD

759 (77.4%)

60 (67.4%)

547 (76.5%)

152 (77.2%)

Other

13 (1.3%)

6 (6.7%)

6 (0.8%)

1 (0.5%)

Biocompatible PD fluid use

428 (42.8%)

33 (37%)

316 (44.2%)

79 (40.1%)

0.31

Height SDS

−1.9 ± 1.7

−1.6 ± 2.1

−1.8 ± 1.6

−2.3 ± 1.8

<0.001

None

595 (59.4%)

54 (60.7%)

428 (59.9%)

113 (57.4%)

0.01

Oral nutritional supplements

218 (21.8%)

24 (27%)

160 (22.4%)

34 (17.3%)

Nutritional supplementation

NG tube

92 (9.2%)

6 (6.7%)

69 (9.6%)

17 (8.6%)

Gastrostomy

96 (9.6%)

5 (5.6%)

58 (8.1%)

33 (16.7%)

Amino acid PD fluid use

12 (1.2%)

4 (4.5%)

5 (0.6%)

3 (1.5%)

0.01

Growth hormone use

64 (6.4%)

3 (3.4%)

50 (7.0%)

11 (5.6%)

0.37

Hemoglobin (g/L)

10.8 ± 1.9

11.0 ± 2.1

10.8 ± 1.9

10.8 ± 1.8

0.61

Serum albumin (g/l)

35.8 ± 6.9

36.2 ± 5.4

35.6 ± 7.2

36.2 ± 6.6

0.512

Blood urea (mg/dl)

96 (63)

93 (64)

97 (63)

93 (62)

0.52

Serum bicarbonate (mM)

23.9 ± 4.3

23.7 ± 4.1

23.9 ± 4.2

24.2 ± 4.7

0.63

Serum phosphorus (mM)

1.8 ± 0.6

1.8 ± 0.6

1.8 ± 0.6

1.7 ± 0.6

0.20

Table 1. Patient and treatment baseline characteristics. Data are expressed as n (%), median (IQR) or
mean ± SD.

Figure 1. Regional variation of nutritional status at start of CPD, sorted by decreasing fraction of patients with
BMI within normal range.

age as risk factors for death on dialysis (Table 3). Whereas BMI SDS per se was not predictive, the interaction
term of BMI SDS and age affected the risk of death at borderline significance (p = 0.06). To further illustrate the
interaction of age and BMI SDS with respect to mortality risk on dialysis, we modeled the hazard ratio of death
by age for patients with a BMI SDS of −2, 0, and 2 (Fig. 5). While the globally increased risk of death of children
younger than 5 years of age is more marked in obese children, at older age underweight children appear at higher
risk of death than obese ones.
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Figure 2. Regional differences in supplementary feeding practices in 386 children <6 years, sorted by
increasing fraction of patients without enteral feeding.

Figure 3. Course of BMI SDS according to nutritional status at start of PD (green: normal BMI, blue:
overweight/obese, red: underweight). Regression lines are based on a mixed model predicting BMI SDS from
duration of PD, nutritional status at start of PD and their interaction.

Parameter Estimate (SE)

P

Intercept

−0.056

(0.259)

0.89

Duration of PD (years)

−0.060

(0.036)

0.09

Glomerulopathy

−0.229

(0.089)

0.01

Other

−0.364

(0.110)

0.001

BMI SDS

−0.456

(0.026)

<0.001

Height SDS

0.113

(0.025)

<0.001

% deviation from estimated dry weight

−0.040

(0.014)

0.01

Serum albumin (g/L)

0.015

(0.006)

0.02

Diagnosis (reference: CAKUT)

Nutritional supplementation (reference: none)
Oral

−0.195

(0.090)

0.03

NGT

0.122

(0.133)

0.36

Gastrostomy

0.633

(0.132)

<0.001

Table 2. Factors predicting prospective annualized change in BMI SDS. Positive change means BMI SDS
increase (702 patients, 1930 differences in BMI SDS).
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(SE)

Hazard ratio

95% Confidence
Interval

0.836

(0.279)

2.307

[1.336, 3.987]

0.001

−0.102

(0.028)

0.903

[0.856, 0.954]

<0.001

Estimate
Comorbidity
Age
BMI SDS
BMI SDS * Age

P

0.136

(0.123)

1.145

[0.900, 1.457]

0.27

−0.028

(0.015)

0.973

[0.945, 1.002]

0.06

Table 3. Risk factors for death on CPD.

Figure 4. Survival of patients with underweight (BMI < 2.5th percentile) (red) and without underweight
(BMI > 2.5th percentile) (green) at last observation (log-rank test: p = 0.03).

Figure 5. Hazard ratios of death according to age and BMI SDS (reference: age = 0, BMI SDS = 0) for a patient
with no comorbidities, based on Cox regression with time dependent variables age, BMI SDS, presence of
comorbidities and the interaction of bmi sds and age.

Discussion

At variance with historical epidemiological studies on nutrition in children with CKD, which focused mainly on
uremic underweight, this study highlights a changing trend of the nutritional status in pediatric end stage kidney disease (ESKD). Both underweight and overweight/obesity were common. Using the 2.5th and the 85th BMI
percentiles as cutoffs for underweight and overweight/obesity respectively, 28.6% of patients receiving CPD, as
compared to an expected 17.5%, exhibited an abnormal body composition.
A relatively low rate of underweight, but an increased prevalence of overweight and obesity was recently also
observed in North American CKD cohorts11,12 and in European children undergoing dialysis13. While it is tempting to merely attribute this trend to the global childhood obesity epidemic, the comprehensive and worldwide
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data collection in the IPPN Registry allowed us to dissect in detail and on a global scale, the impact of macroeconomic factors, patient characteristics, and pediatric CKD and dialysis management practices on nutritional
outcome.
The regional breakdown and comparison with the general childhood population prevalence data revealed that
overweight and obesity in the CPD patients was indeed most prevalent in children and adolescents from the US
and the Middle East, and comparable to the national prevalence rates in these countries which show the highest
prevalence of childhood obesity worldwide14. On the other hand, when relating the observed obesity rates to the
current prevalences in the general pediatric populations of the respective regions, obesity was slightly less common in patients from Western Europe, but was substantially more frequent in children from South and South East
Asia14. The latter finding might be explained in part by overrepresentation of families from upper socioeconomic
strata to whom chronic dialysis is affordable. Noteworthy also was the finding that whereas gross national income
was positively correlated with overweight/obesity prevalence by univariate analysis, it was not included in the
multivariate models predicting BMI at initiation of dialysis and during follow-up. This suggests that the observed
regional differences can be explained in large part by the medical factors included in the multivariate analysis.
Two factors were consistently associated with BMI SDS at the time of PD initiation: the most current eGFR
and the use of gastrostomy feeding prior to PD start. The positive association with eGFR is compatible with the
notion that the risk of uremic underweight increases as residual kidney function declines in the late pre-dialytic
phase. Centers in countries where late referral to pediatric nephrology care is common may be more likely to
start PD in underweight patients with little residual kidney function. In the case of children for whom PD is to be
started electively, our findings add a nutritional perspective to the list of factors to be considered when determining the optimal timing of PD initiation.
The most important single factor associated with higher BMI SDS both at PD start and during follow-up was
the presence of a gastrostomy. In the multivariate longitudinal analysis, gastrostomy feeding accounted for an
increase in BMI by almost two standard deviations per three years of treatment. Accordingly, gastrostomy feeding
was almost three times more common among overweight and obese as compared to underweight patients. These
findings confirm and extend a previous IPPN study in young infants, which identified PEG feeding as a risk factor
for obesity2. Since the use of gastrostomy feeding was found to be largely restricted to high-income countries,
enteral feeding via gastrostomy appears to be the most important factor underlying the observed link between
Gross National Income and higher BMI.
An unexpected observation was the fact that obese - but not underweight - patients were significantly shorter
than patients with normal nutritional status at the initiation of renal replacement therapy. This finding, which is
in keeping with recent findings in the ESPN/ERA-EDTA registry13 and previous reports15, may reflect previous
frustraneous interventions to correct growth failure by hypercaloric feeding.
An important and reassuring finding from the longitudinal analysis is the observation that nutritional abnormalities, both underweight and overweight/obesity, tend to level off over the course of dialysis. The prevailing
BMI SDS was a highly significant inverse predictor of the subsequent change in BMI SDS in the longitudinal
model. This ‘funneling’ of the nutritional status is likely to be a consequence of regular nutritional monitoring
and dietary advice. Direct effects of dialysis such as control of uremia, correction of acidosis and dialytic glucose
resorption probably play a role in the correction of underweight, but these factors were not included as significant predictors of prospective BMI SDS change in the overall model since they are less likely to increase BMI in
patients with normal nutritional status.
Remarkably, patients with congenital kidney malformation disorders (CAKUT) were more likely to gain BMI
SDS over the course of dialysis than patients with other underlying renal diseases. Since CAKUT is the most
common renal diagnosis in infants with ESKD and was slightly more common among initially underweight
patients, we speculate that catch-up weight gain due to enteral feeding was more common in this patient group.
In addition, as CAKUT patients are often polyuric even at commencement of dialysis, part of the observed BMI
gain may be explained by relative fluid gain to the gradual loss of diuresis with time on PD.
The estimated fractional deviation from dry weight was associated with a subsequent negative change in BMI
SDS, possibly reflecting the impact of early fluid imbalances (e.g. hypervolemia) and their correction with time
on CPD. When patients with substantial fluid overload have their body weight decreased because of improved
fluid management, this will be recorded as a negative change in BMI, illustrating the limitation of BMI SDS as a
measure of nutritional status.
Nutritional status is a well recognized, major global determinant of mortality in the general adult and pediatric population, as well as in adults and children with ESKD16–18. The overall patient survival observed in this
global sample of children and adolescents starting CPD (91% at 2 years) was not dissimilar from survival rates
noted in North American and European registry cohorts19–21. Wong et al., in the only other large study examining
BMI and mortality in pediatric ESRD, demonstrated a U-shaped association between the risk of death and BMI
SDS, with both extremes of BMI associated with increased mortality19. An increased death risk was also observed
in children with a hematological malignancy who were either underweight or obese22. In the present study,
underweight patients were twice as likely to die on dialysis as non-underweight children by univariate Kaplan
Meier survival analysis, whereas obesity did not affect the risk of death. On the other hand, when accounting for
age and the presence of comorbidities in a Cox regression model, although BMI SDS did not predict the risk of
death, age and BMI SDS showed an interactive effect; specifically, an increased infant mortality was amplified by
obesity, whereas mortality in older children and adolescents was markedly increased by underweight. Hence, our
findings are compatible with an age-dependent impact of the extremes of body composition on patient survival.
We hypothesize that the morbid obesity generated in a subset of young infants by enteral feeding may, in fact,
put these patients at increased risk of death. Possible underlying causes of this risk association might include
enhanced cardiovascular risk due to the difficulty of assessing fluid status in obese infants and the susceptibility
of obese subjects to severe outcomes following viral respiratory infections23.
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While the strength of our study relates to the robust set of data available from a large group of pediatric CPD
patients, several limitations of our study should be mentioned. Although BMI is a generally accepted method to
assess nutritional status in healthy children24–26, it is an imperfect measure of body composition. This is particularly true in pediatric dialysis patients as it does not account for abnormalities of fluid status and is impacted by
abnormal body height. While the latter issue was accounted for by calculation of BMI SDS for height age27,28, a
more refined auxological assessment was not possible in this global registry. Another important limitation of our
study was the lack of detailed data on dietary prescriptions and caloric intake, which would be difficult to obtain
due to complexity of data collection in such a large and diverse cohort of patients.
In summary, this longitudinal assessment of 1001 children from 35 countries commencing CPD demonstrates that both underweight and obesity are observed at increased frequency in pediatric ESRD. The prevalence
of both abnormalities varies substantially across the globe. Delayed start of dialysis is a risk factor for underweight whereas enteral tube feeding, while protecting from underweight, increases the risk of developing obesity.
Nutritional abnormalities tend to attenuate with time on dialysis.
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